Changes to Mexican patent and health laws for life sciences

Presented by

Eileen McDermott, moderator

About this talk

Life sciences companies doing business in Mexico will need strategies for navigating recent changes to the patent and health laws that may present new challenges to patent holders. This web seminar will explain how new draft regulations could affect the biologics market, in addition to explaining and providing tips on the new regulations for data package exclusivity rights and amendments to the patent law. Speakers: Eileen McDermott, Managing IP (moderator) Alejandro Luna, Co Chair and Partner, Life Sciences and Pharma Law Group, Olivares & Cia, Mexico Cesar Ramos, Head of the Patent Group, Olivares & Cia, Mexico, Johnathan Acevas, Regional Brand Regulatory Manager of Oncology, Latin America, Novartis, Mexico

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (85)
Subscribers (11222)
‘What keeps in-house counsel awake at night?’ is one way to summarise our editorial focus. We aim to track the strategies of in-house IP counsel within companies, big and small, by speaking directly to them about the day-to-day issues they face. Law firms need practical information that they can apply when advising their clients, and companies find value in benchmarking their strategies with those of their peers. This is why we have adopted this approach in our subscription-based service. Our content is not reactionary or news-focused, but informed and actionable. In this pursuit of in-house intelligence, we also publish several surveys each year that include exclusive data focusing on specific industry issues. These polls allow us to provide an accurate snapshot of how in-house counsel perceive and act on a given issue. Our other core objective is interviewing senior judges, whose insight is valuable for many IP stakeholders. We find that the judiciary are vital for giving counsel, private and in-house, highly useful information for when they are locked in litigation. We continue to speak regularly with IP offices too. Regardless of its specific intent, our coverage is global and encompasses (but is not limited to) the following areas: Copyright; Data; Designs; Patents; Trademarks; and Trade secrets